SEVERAL STUDIES have shown that a parental history of coronary heart disease (CHD) is predictive of CHD in male adults.1-4 Adjustment for classic risk factors (age, blood pressure, plasma cholesterol, cigarette consumption, diabetes) usually reduces slightly the strength of this relationship but fails to remove it completely. As a consequence, it is necessary to look for other factors (see ref. 5 for an in-depth review). In particular, since plasma lipoprotein abnormalities appear to be the essential characteristics predisposing to atherosclerosis, it is of interest to investigate the relationship between parental history of CHD and the level of plasma lipids and apoproteins. Several case-control studies have suggested that plasma apoproteins A1
SEVERAL STUDIES have shown that a parental history of coronary heart disease (CHD) is predictive of CHD in male adults.1-4 Adjustment for classic risk factors (age, blood pressure, plasma cholesterol, cigarette consumption, diabetes) usually reduces slightly the strength of this relationship but fails to remove it completely. As a consequence, it is necessary to look for other factors (see ref. 5 for an in-depth review). In particular, since plasma lipoprotein abnormalities appear to be the essential characteristics predisposing to atherosclerosis, it is of interest to investigate the relationship between parental history of CHD and the level of plasma lipids and apoproteins. Several case-control studies have suggested that plasma apoproteins A1 (APOAl) and B (APOB) are more strongly associated with CHD than the lipoprotein cholesterol subfractions.`l However, it is impossible to infer from these results that apoproteins are more relevant than the lipoprotein fractions of cholesterol in determining the risk of CHD, since this particular pattern of lipoprotein abnormalities could be consecutive to the atherosclerotic process (or to the changes in lifestyle accompanying it) and might not precede it. Prospective investigations are clearly needed to solve this issue. However, family data, especially when they are obtained from whole populations to avoid the selection biases potentially occurring in case-control studies, may help to elucidate the nature of these relationships. Freedman et al.`2 have recently reported results from the Bogalusa Heart Study indicating that the mean level of APOAl was significantly reduced in children with a parental history of myocardial infarction whereas the mean level of APOB was not affected. In this analysis of the baseline data of the Paris Prospective Study 2 (PPS2), our purpose is to explore the interrelationships be-tween parental history of early myocardial infarction, lipids, and APOAl and APOB, and more specifically to determine whether APOAI and APOB are more strongly related to parental history than high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol.
Methods
The PPS2 is an investigation on cardiovascular risk factors begun in 1982. The initial screening phase ended in December 1985 and the follow-up of the 4547 subjects (20 to 60 years old) who entered the study is presently under way. The study population is composed of male employees of large public organizations in Paris who were volunteers for a cardiovascular screening. Each subject was interviewed by a technician and had to answer a series of questionnaires on smoking habits, alcohol consumption, and a questionnaire on parental history of cardiovascular disease. The latter questionnaire was principally aimed at evaluating the parental history of myocardial infarction, which is more reliable than the history of angina pectoris, peripheral arterial disease, stroke, or hypertension. When a disease was reported, the interviewer had to ask for its circumstances and consequences to obtain a reasonable confidence in the reported history. The age of first occurrence of the disease also was noted. There was no other source of information concerning the parental history than this questionnaire. The subjects were then examined by a doctor and had their clinical history noted. All subjects having a clinical history of myocardial infarction, angina pectoris, or peripheral artery disease and all those taking hypolipidemic drugs were not included in the analysis (n = 150). Body mass index (BMI) was expressed as weight on height squared (kg/M2).
Biochemical methods. Until July 1983, cholesterol was determined by an automatic procedure based on the LiebermannBurchard reaction.'3 After this date, an automatic enzymatic procedure was used (Technicon SMA system). Duplicate measurements of serum cholesterol were performed on a group of 200 subjects to assess the comparability of the two methods. The correlation between the two methods was .97, but a lower mean level (10 mg/dl) was observed with the enzymatic procedure. This discrepancy was taken into account in the statistical analysis. HDL cholesterol was measured after precipitation of very low-density lipoproteins (VLDL) and LDL cholesterol by a heparin-manganese reagent. 14 An estimate of the LDL cholesterol level was computed with the following formula: LDL cholesterol = total cholesterol -(HDL cholesterol + 0.16 x triglycerides). According to the results of the Lipid Research Clinics study,15 this formula is more accurate than the classic Friedewald formula,16 in which the coefficient for triglycerides is 0.2 instead of 0. 16, and it gives a good approximation of LDL cholesterol, even in hypertriglyceridemic subjects. The triglycerides were measured by an enzymatic procedure (Technicon SMA system). APOAI and APOB were assayed simultaneously by immunoelectrodiffusion. 17 The percentage of linoleic acid in the cholesterol esters was estimated by gas chromatography as described previously.'8 A detailed description (in French) of the biochemical methods used for the measurement of lipoproteins and apoproteins and of their reproducibility is available from the authors upon request.
Statistical analysis. Since the method of measurement of cholesterol changed during the study, a two-period adjustment was performed for all the presented comparisons, even those that do not involve cholesterol; this was equivalent to a poststratification on a dichotomous variable defining the period. The adjustment on covariates and on period was performed in the following way: the multiple regression coefficients of each dependent variable on the different covariates and period were estimated separately in the groups with or without a parental history of myocardial infarction. Since the values of the regression coefficients in the two groups were not significantly different (at the .05 level) for any of the covariates or period, the multiple regression coefficients were estimated in the whole population and used to compute individual values, adjusted on each covariate. The means and standard deviations of these adjusted variables are given in the tables and are used in the comparisons of the subjects with or without a parental history of myocardial infarction. A stepwise discriminant analysis was performed to test for independent relationship between the different lipid variables and parental myocardial infarction. The programs BMDP1D, BMDP1V, and BMDP7M'9 were used to perform this statistical analysis.
Results
After exclusion of the subjects with a personal history of myocardial infarction, angina pectoris, or peripheral arterial disease, those treated with hypolipidemic drugs, and those with missing data, 4045 subjects remained for the analysis. Among them, 305 reported a paternal and 94 a maternal history of myocardial infarction. When compared with subjects with no parental myocardial infarction, those with a paternal history of myocardial infarction had a slight elevation of APOB (98.2 vs 94.7 mg/dl; p <.05) and those with a maternal history of myocardial infarction had lower HDL cholesterol levels (54.6 vs 57.9 mg/dl; p <.01). An age limit of 60 was chosen a priori to define early parental myocardial infarction; no other grouping was attempted. The numbers of subjects with early paternal or maternal myocardial infarction were 123 and 30, respectively. One subject whose parents both had an early myocardial infarction was arbitrarily classified with those having a paternal history. Late parental myocardial infarction (60 years or later) was unrelated to any of the variables studied; as a consequence, the subjects with such parental history were classified with those with no parental myocardial infarction.
The main characteristics of the study population are given in Since a major environmental factor affecting LDL cholesterol and APOB is the lipid composition of the diet, the percentage of linoleic acid in the fatty acids of plasma cholesterol esters (LA) was used as a marker of this composition to investigate a potential difference in the type of lipid intake in subjects with or without a parental history of early myocardial infarction. LA was measured in 3653 subjects, among whom 108 had a paternal history of myocardial infarction and 29 had a maternal history of myocardial infarction. The mean percentages of LA in the subjects with a parental history of early myocardial infarction (47.7 ± 6.1% SD) and in subjects with no such history (48.2 ± 5.6% SD) are not different, suggesting that the association between a parental history of early myocardial infarction and LDL cholesterol and APOB is not likely to be the consequence of a familial resemblance in the type of fat consumed.
Discussion
The associations demonstrated by the present analysis should be interpreted with the relative imprecision of the information on parental history kept in mind. The specificity of the responses concerning early parental history of myocardial infarction has not been evaluated in this work and it is likely that some falsenegative and false-positive responses were reported; however, if the responses were not biased, the only consequence of this imprecision would be a reduction in the strength of the observed relationships. Could some biases explain the results? We can hypothesize that subjects who suffered from a myocardial infarction or a related disease such as angina pectoris or peripheral arterial disease were more prone to report a positive parental history of myocardial infarction for two reasons: first because there is a familial aggregation for this disease,' -4 and second because these patients are more concerned and less likely to omit a parental antecedent. The exclusion from the analysis of the subjects who had a myocardial infarction, angina pectoris, or a peripheral arterial disease and of those treated with hypolipidemic drugs is likely to reduce this bias considerably. Delong et al. 5 have recently proposed a formula to estimate LDL cholesterol from the measurements of total cholesterol, HDL cholesterol, and triglycerides that appears to be more accurate than the classic Friedewald formula,'6 especially in hypertriglyceridemic subjects. When applied to our data, this formula leads to an estimate of LDL cholesterol that is slightly more strongly correlated with the covariates (BMI, cigarette consumption, alcohol consumption, and age) than the estimate obtained from Friedewald's formula; however, the two estimates are similarly associated with parental history of myocardial infarction.
The results show that a parental history of early myocardial infarction is associated with a substantial increase of LDL cholesterol and APOB levels with no changes of APOA 1 and triglyceride levels. The results of the discriminant analysis suggest that APOB is more strongly related with parental myocardial infarction than LDL cholesterol. Some authors have used the ratio LDL cholesterol/LDL APOB to look for a possible disproportionate increase of APOB relative to LDL cholesterol in some patients with coronary heart disease. 20 In the Bogalusa study,'2 the ratio LDL cholesterol/total APOB (an approximation of the above ratio) was decreased in children with a paternal history of myocardial infarction. In our study, this ratio was not related with paternal or maternal myocardial infarction. Thus there is no evidence of a disproportionate increase of APOB relative to LDL cholesterol in patients with a parental history of myocardial infarction. Parental history of myocardial infarction has already been shown to be associated with increased levels of lipids and apoproteins. Freedman et al. 2 have recently reported results from the Bogalusa Heart Study showing an association between APOA 1 and parental history of myocardial infarction in children, whereas there was no statistically significant association between parental history and APOB. Furthermore, the ratios APOB/APOA I and APOB/LDL cholesterol were both raised in children with a paternal history of myocardial infarction. In their study, De Backer et al.2`have obtained very similar results; they have measured the levels of lipids and apoproteins in the offspring of patients who suffered a myocardial infarction before age 50 and found that, when compared with controls, they had a lower mean level of APOA 1 and higher ratios (VLDL cholesterol + LDL cholesterol)/APOB and HDL cholesterol/APOA1. On the other hand, in the same study, in male offspring the mean levels of APOB, LDL cholesterol (estimated by the Friedewald formula), HDL cholesterol, and triglycerides did not differ significantly between the two groups. Kukita et al. 22 have compared first-degree relatives of patients with angiographically defined coronary artery disease with control subjects and found that they had a lower level of APOAl and HDL cholesterol and a higher level of APOB and triglycerides. In the study of Van Stiphout et al.,23 a paternal history of severe atherosclerosis (estimated by coronary angiography) was associated in offspring with higher levels of APOB and of the ratio APOB/APOA1. LDL cholesterol was also raised in these children but not significantly, and the mean level of APOA1 was similar to that of controls.
There are some discrepancies among the studies. Some point to the more important role played by APOA1, whereas others, like the PPS2, point to the important role played by APOB. Nevertheless, all the results are concordant in showing a stronger association of CHD with apoprotein levels than with the lipoprotein cholesterol subfractions. This observation is in agreement with the results of many casecontrol studies involving patients with coronary atherosclerosis.6 ' We cannot explain the lack of relationship between HDL cholesterol or APOAl and parental history of early myocardial infarction in the PPS2. The population of the Bogalusa Heart Study is composed of chil- 
